Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction

Clinical Pharmacokinetics

Volumn 41, Issue 12, 2002, Pages 999-1004

  Pique J M ^a   Feu, F ^a   De Prada, G ^a   Rohss K ^b   Hasselgren, G ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYOMEPRAZOLE; OMEPRAZOLE; OMEPRAZOLE SULFONE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG INFUSION; DRUG TOLERANCE; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HALF LIFE TIME; HEPATIC ENCEPHALOPATHY; HISTORY OF MEDICINE; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; SCREENING;

EID: 0036394803     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200241120-00004     Document Type: Article

References (10)

1. Kiilerich S, Rannem T, Elsborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56: 25-30
2. Andersson T, Olsson R, Regårdh CG, et al. Pharmacokinetics of [14C]omeprazole in patients with liver cirrhosis. Clin Pharmacokinetics 1993; 24 (1): 71-8
3. Pugh PMH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-64
4. Lagerström PO, Persson BA. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. J Chromatogr 1984; 309: 347-56
5. Andersen J, Ström M, Naesdal J, et al. Intravenous omeprazole: effect of a loading dose on 24-h intragastric pH. Aliment Pharmacol Ther 1990; 4: 65-72
6. Andersson T, Regärdh C-G. Pharmacokinetics of omeprazole and metabolites following single intravanenous and oral doses of 40 and 80mg. Drug Invest 1990; 2 (4): 255-63
7. Regärdh CG, Andersson T, Lagerström PO, et al. The pharmacokinetics of omeprazole in humans: a study of single intravenous and oral doses. Ther Drug Monit 1990; 12: 163-72
8. Andersson T. Pharmacokinetics, metabolism and interaction of acid pump inhibitors: focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 1996; 31 (1): 9-28
9. Adedoyin A, Arns PA, Richards WE, et al. Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6. Clin Pharmacol Ther 1998; 64 (1): 8-17
10. Arns PA, Wilkenson GR, Branch RA. The stereoselective disposition of mephenytoin provides a probe of hepatic function and development of portasystemic shunts in liver disease [abstract]. Hepatology 1998; 8: 1277